Clinical trial
ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of…
NCT00246168 · Janssen Korea, Ltd., Korea, Industry · Completed
Key facts
| NCT number | NCT00246168 |
|---|---|
| Title | ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain. |
| Official title | ULTRACET (Tramadol Hydrochloride and Acetaminophen) add-on Therapy for the Treatment of the Pain of Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled Study |
| Lead sponsor | Janssen Korea, Ltd., Korea, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | tramadol hydrochloride + acetaminophen |
| Enrollment | 277 |
| Completion | Jun 1, 2005 |
| First posted | Oct 31, 2005 |
| Last update posted | Nov 30, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: